The remote tracking path will become more and more specialized
With the development of remote consultation, remote tracking as its main auxiliary means has also achieved certain development. The main advantage of remote tracking is that it collaborates with other parts of the treatment process, which requires that it must provide more specialized products and services than ordinary detection data. Data provided by mass wearable devices may only be used as a reference and not as a basis for clinical diagnosis.
Therefore, the development of remote tracking must start with specialized products and services, mainly for medical institutions, as an important auxiliary means for hospitals and doctors. Through the medical institutions to establish a reputation in the industry, and then through the integration of mass-type products to serve customers in all aspects.
Recently, the US remote tracking company Vivify Health received a total investment of 15 million US dollars from the third-party independent testing company LabCorp and Envision. Vivify Health's Care Management Platform helps patients actively participate in their care. The platform can be run on a variety of mobile devices, integrating user-entered data and data collected by non-invasive peripheral medical devices (such as weight scales) into a medical information system, and then sending the data in a secure manner Nursing staff.
As the largest third-party independent testing company in the United States, why does LabCorp choose to invest in Vivify Health? The main reasons are three: the future development of remote tracking is increasingly biased towards independent testing by third parties. Through professional-grade equipment, users can obtain more accurate data under the guidance of medical staff. These data can provide an important basis for remote consultation. Second, professional data on remote tracking will help the development and optimization of new drugs and medical devices. Third, remote consultation will become an important distribution channel for medical services in the future, which is unmatched by offline third-party testing.
Vivify Health's main sales target is hospitals, not individuals. Currently, Vivify Health has partnered with more than 250 hospitals across the United States. Its remote patient management platform is a software-as-a-service (SaaS) system that, in addition to its own sales, is bundled with EHR and analytics software. Vivify Health is also bundled with the Polycom Questioning Platform, which allows users to immediately start a video and communicate with healthcare professionals in real time.
From the development of Vivify, remote tracking itself is a technically specialized, more specialized service that has developed in collaboration with other medical treatments. First, solve the problem of who pays by selling software for the hospital. At the same time, in the cooperation with the hospital, Vivify has optimized the product and established a reputation. The hospital, through remote monitoring, also controls the user's disease and reduces the cost of medical care.
Vivify intends to integrate data from other popular platforms, such as working with Samsung and Apple's health platform, to import this data into its own platform to provide more reference for diagnosis and treatment. From the example of Vivify, the path of remote tracking has become clearer. From the professional product and management, to the professional medical service fields such as medical institutions, through the collaboration with other medical treatments to develop, and finally to incorporate popular products. .
From this perspective, the development of remote tracking in China may be earlier than other parts of Internet medical care. Taking the hospital as the main sales target will help to avoid the current situation of the lack of payment parties. Specialization will help the deep cultivation of products and services, and avoid the popular products of the virtual fire. However, even if the hospital adopts this service system, whether it can be included in the medical insurance will be a big test. If this service cannot be included in health care, the number of users may not grow too fast, or it is not conducive to the development of remote tracking companies.
For the most common waxy and sweet corn on the market, waxy corn has a higher nutrient content than regular corn, containing 70-75% starch (and almost all straight-chain starch), more than 10% protein, 4-5% fat and 2% multivitamins, with more grains, VA, VB1 and VB2 in protein than rice, with the highest fat and VB2 content. Yellow maize also contains carotenoids, such as rice and wheat. The molecular weight of waxy maize starch is more than 10 times smaller than that of ordinary maize, and the starch makes glutinous rice sticky and soft, softer than ordinary hard maize. It is more than 20% more digestible to eat than regular maize and it is suitable for people with less than perfect teeth. At the same time, it is not suitable for diabetics because of the very high content of straight-chain starch (a polysaccharide).
Waxy maize is also known as sticky maize. The grain has coarse, waxy endosperm, similar to shiny, glassy (clear) grains such as hard and dent maize. Its chemical and physical characteristics are controlled by a recessive gene, which is located on chromosome 9. 100% of the starch in the endosperm is straight-chain starch.
Healthy Corn Food To Eats,Fresh Corn Kernel,Instant Food Corn,Organic Sweet Corn
Jilin Province Argricultural Sister-in-law Food Co., Ltd. , https://www.nscorn.com